141 related articles for article (PubMed ID: 18503232)
1. Absence of a trafficking defect in R1232W/T1620M, a double SCN5A mutant responsible for Brugada syndrome.
Makita N; Mochizuki N; Tsutsui H
Circ J; 2008 Jun; 72(6):1018-9. PubMed ID: 18503232
[TBL] [Abstract][Full Text] [Related]
2. Expression and intracellular localization of an SCN5A double mutant R1232W/T1620M implicated in Brugada syndrome.
Baroudi G; Acharfi S; Larouche C; Chahine M
Circ Res; 2002 Jan; 90(1):E11-6. PubMed ID: 11786529
[TBL] [Abstract][Full Text] [Related]
3. A sodium channel pore mutation causing Brugada syndrome.
Pfahnl AE; Viswanathan PC; Weiss R; Shang LL; Sanyal S; Shusterman V; Kornblit C; London B; Dudley SC
Heart Rhythm; 2007 Jan; 4(1):46-53. PubMed ID: 17198989
[TBL] [Abstract][Full Text] [Related]
4. Mutation in glycerol-3-phosphate dehydrogenase 1 like gene (GPD1-L) decreases cardiac Na+ current and causes inherited arrhythmias.
London B; Michalec M; Mehdi H; Zhu X; Kerchner L; Sanyal S; Viswanathan PC; Pfahnl AE; Shang LL; Madhusudanan M; Baty CJ; Lagana S; Aleong R; Gutmann R; Ackerman MJ; McNamara DM; Weiss R; Dudley SC
Circulation; 2007 Nov; 116(20):2260-8. PubMed ID: 17967977
[TBL] [Abstract][Full Text] [Related]
5. Distinct functional defect of three novel Brugada syndrome related cardiac sodium channel mutations.
Hsueh CH; Chen WP; Lin JL; Tsai CT; Liu YB; Juang JM; Tsao HM; Su MJ; Lai LP
J Biomed Sci; 2009 Feb; 16(1):23. PubMed ID: 19272188
[TBL] [Abstract][Full Text] [Related]
6. A heterozygous deletion mutation in the cardiac sodium channel gene SCN5A with loss- and gain-of-function characteristics manifests as isolated conduction disease, without signs of Brugada or long QT syndrome.
Zumhagen S; Veldkamp MW; Stallmeyer B; Baartscheer A; Eckardt L; Paul M; Remme CA; Bhuiyan ZA; Bezzina CR; Schulze-Bahr E
PLoS One; 2013; 8(6):e67963. PubMed ID: 23840796
[TBL] [Abstract][Full Text] [Related]
7. Electrophysiological and trafficking defects of the SCN5A T353I mutation in Brugada syndrome are rescued by alpha-allocryptopine.
Zhang J; Chen Y; Yang J; Xu B; Wen Y; Xiang G; Wei G; Zhu C; Xing Y; Li Y
Eur J Pharmacol; 2015 Jan; 746():333-43. PubMed ID: 25261036
[TBL] [Abstract][Full Text] [Related]
8. Compound heterozygous mutations P336L and I1660V in the human cardiac sodium channel associated with the Brugada syndrome.
Cordeiro JM; Barajas-Martinez H; Hong K; Burashnikov E; Pfeiffer R; Orsino AM; Wu YS; Hu D; Brugada J; Brugada P; Antzelevitch C; Dumaine R; Brugada R
Circulation; 2006 Nov; 114(19):2026-33. PubMed ID: 17075016
[TBL] [Abstract][Full Text] [Related]
9. Analyses of a novel SCN5A mutation (C1850S): conduction vs. repolarization disorder hypotheses in the Brugada syndrome.
Petitprez S; Jespersen T; Pruvot E; Keller DI; Corbaz C; Schläpfer J; Abriel H; Kucera JP
Cardiovasc Res; 2008 Jun; 78(3):494-504. PubMed ID: 18252757
[TBL] [Abstract][Full Text] [Related]
10. Subepicardial phase 0 block and discontinuous transmural conduction underlie right precordial ST-segment elevation by a SCN5A loss-of-function mutation.
Bébarová M; O'Hara T; Geelen JL; Jongbloed RJ; Timmermans C; Arens YH; Rodriguez LM; Rudy Y; Volders PG
Am J Physiol Heart Circ Physiol; 2008 Jul; 295(1):H48-58. PubMed ID: 18456723
[TBL] [Abstract][Full Text] [Related]
11. A novel strategy using cardiac sodium channel polymorphic fragments to rescue trafficking-deficient SCN5A mutations.
Shinlapawittayatorn K; Dudash LA; Du XX; Heller L; Poelzing S; Ficker E; Deschênes I
Circ Cardiovasc Genet; 2011 Oct; 4(5):500-9. PubMed ID: 21840964
[TBL] [Abstract][Full Text] [Related]
12. Characterization of a novel Nav1.5 channel mutation, A551T, associated with Brugada syndrome.
Chiang KC; Lai LP; Shieh RC
J Biomed Sci; 2009 Aug; 16(1):76. PubMed ID: 19706159
[TBL] [Abstract][Full Text] [Related]
13. Lidocaine-induced Brugada syndrome phenotype linked to a novel double mutation in the cardiac sodium channel.
Barajas-Martínez HM; Hu D; Cordeiro JM; Wu Y; Kovacs RJ; Meltser H; Kui H; Elena B; Brugada R; Antzelevitch C; Dumaine R
Circ Res; 2008 Aug; 103(4):396-404. PubMed ID: 18599870
[TBL] [Abstract][Full Text] [Related]
14. The complexity of genotype-phenotype relations associated with loss-of-function sodium channel mutations and the role of in silico studies.
Wilde AA; Coronel R
Am J Physiol Heart Circ Physiol; 2008 Jul; 295(1):H8-9. PubMed ID: 18502906
[No Abstract] [Full Text] [Related]
15. A novel mechanism associated with idiopathic ventricular fibrillation (IVF) mutations R1232W and T1620M in human cardiac sodium channels.
Vilin YY; Fujimoto E; Ruben PC
Pflugers Arch; 2001 May; 442(2):204-11. PubMed ID: 11417215
[TBL] [Abstract][Full Text] [Related]
16. Novel SCN5A mutation (Q55X) associated with age-dependent expression of Brugada syndrome presenting as neurally mediated syncope.
Makita N; Sumitomo N; Watanabe I; Tsutsui H
Heart Rhythm; 2007 Apr; 4(4):516-9. PubMed ID: 17399644
[TBL] [Abstract][Full Text] [Related]
17. A novel mutation in the SCN5A gene is associated with Brugada syndrome.
Shin DJ; Kim E; Park SB; Jang WC; Bae Y; Han J; Jang Y; Joung B; Lee MH; Kim SS; Huang H; Chahine M; Yoon SK
Life Sci; 2007 Jan; 80(8):716-24. PubMed ID: 17141278
[TBL] [Abstract][Full Text] [Related]
18. Readthrough of nonsense mutation W822X in the SCN5A gene can effectively restore expression of cardiac Na+ channels.
Teng S; Gao L; Paajanen V; Pu J; Fan Z
Cardiovasc Res; 2009 Aug; 83(3):473-80. PubMed ID: 19377070
[TBL] [Abstract][Full Text] [Related]
19. Novel mechanism for Brugada syndrome: defective surface localization of an SCN5A mutant (R1432G).
Baroudi G; Pouliot V; Denjoy I; Guicheney P; Shrier A; Chahine M
Circ Res; 2001 Jun; 88(12):E78-83. PubMed ID: 11420310
[TBL] [Abstract][Full Text] [Related]
20. Partial expression defect for the SCN5A missense mutation G1406R depends on splice variant background Q1077 and rescue by mexiletine.
Tan BH; Valdivia CR; Song C; Makielski JC
Am J Physiol Heart Circ Physiol; 2006 Oct; 291(4):H1822-8. PubMed ID: 16632547
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
